S&P 500   2,999.25 (+0.44%)
DOW   26,799.26 (+0.11%)
QQQ   192.84 (+0.60%)
MSFT   138.23 (+0.60%)
CGC   20.21 (+0.00%)
NVDA   193.21 (+1.43%)
MU   44.09 (+1.43%)
BABA   172.56 (+2.03%)
AMD   31.65 (+2.20%)
F   9.20 (-0.97%)
ACB   3.69 (+0.27%)
NFLX   273.11 (-0.80%)
BAC   30.70 (+1.15%)
GILD   65.13 (+0.34%)
DIS   131.05 (+0.12%)
S&P 500   2,999.25 (+0.44%)
DOW   26,799.26 (+0.11%)
QQQ   192.84 (+0.60%)
MSFT   138.23 (+0.60%)
CGC   20.21 (+0.00%)
NVDA   193.21 (+1.43%)
MU   44.09 (+1.43%)
BABA   172.56 (+2.03%)
AMD   31.65 (+2.20%)
F   9.20 (-0.97%)
ACB   3.69 (+0.27%)
NFLX   273.11 (-0.80%)
BAC   30.70 (+1.15%)
GILD   65.13 (+0.34%)
DIS   131.05 (+0.12%)
Log in

PlusTherapeuticsInc . Earnings Date, Estimates & History (NASDAQ:PSTV)

$2.56
-0.10 (-3.76 %)
(As of 10/21/2019 09:30 AM ET)
Today's Range
$2.56
Now: $2.56
$2.65
50-Day Range
$2.33
MA: $6.92
$18.00
52-Week Range
$2.16
Now: $2.56
$24.45
Volume10,350 shs
Average Volume1.06 million shs
Market Capitalization$1.15 million
P/E RatioN/A
Dividend YieldN/A
Beta1.59

Earnings

PlusTherapeuticsInc . (NASDAQ:PSTV) Earnings History and Estimates Chart

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PlusTherapeuticsInc . (NASDAQ PSTV) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/13/2019
(Estimated)
       
8/15/2019Q2($9.75)($5.12)$10.43$0.30 millionN/A
5/14/2019Q1 2019($9.00)($9.00)$0.70 millionN/A
4/1/2019Q4 2018($10.00)($12.00)$1.10 millionN/A
11/14/2018Q3 2018($6.50)($22.50)($17.50)$3.24 million$1.31 millionN/A
8/14/2018Q2 2018($24.50)($29.50)($29.50)$2.50 million$1.56 millionN/A
5/10/2018Q1 2018($20.00)($35.00)($35.00)$2.43 million$0.73 millionN/A
3/8/2018Q4 2017($50.00)($50.00)$2.00 million$1.50 millionN/A
11/9/2017Q3 2017($80.00)($70.00)($70.00)$2.04 million$1.77 millionN/A
8/10/2017Q2 2017($80.00)($90.00)($85.00)$2.15 million$1.50 millionN/A
5/11/2017Q1 2017($135.00)($130.00)($95.00)$3.12 million$1.61 millionN/A
3/23/2017Q4 2016($130.00)($120.00)($120.00)$2.98 million$1.47 millionN/A
11/9/2016Q3 2016($235.00)($130.00)($130.00)$0.73 millionN/A
8/4/2016Q2 2016($245.00)($215.00)($215.00)$2.93 million$1.13 millionN/A
5/10/2016Q1 2016($3,073.46)($3,073.46)$2.92 millionN/A
3/3/2016Q4 2015($299.85)($224.89)($299.85)$2.90 million$1.56 millionN/A
11/5/2015Q3 2015($449.78)($299.85)($674.66)$0.77 millionN/A
8/6/2015Q2 2015($74.96)($224.89)($674.67)$2.78 million$1.61 millionN/A
5/11/2015Q1 2015($599.70)($524.74)$524.73$2.57 million$2.35 millionN/A
3/12/2015Q4 2014($824.59)($599.70)($599.70)$1.95 million$3.77 millionN/A
11/6/2014Q3 2014($674.66)($899.55)($899.55)$4.31 million$1.10 millionN/A
8/11/2014Q2 2014($824.59)($1,124.44)($1,124.44)$2.76 million$0.94 millionN/A
5/12/2014Q1 2014($974.51)($1,049.48)($1,049.48)$3.42 million$1.03 millionN/A
3/11/2014Q4 2013($899.55)($1,049.48)($1,049.48)$3.25 million$2.71 millionN/A
11/7/2013Q3 2013($824.59)($599.70)($599.70)$2.97 million$1.62 millionN/A
8/8/2013Q2 2013($974.51)($899.55)($1,424.29)$2.52 million$1.41 millionN/A
5/9/2013Q1 2013($1,199.40)($824.59)($824.59)$3.24 million$1.39 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: Strangles

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel